Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Assets: 2020-2025

Historic Other Non-Current Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $49.4 million.

  • Maravai Lifesciences Holdings' Other Non-Current Assets fell 18.91% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year decrease of 18.91%. This contributed to the annual value of $59.8 million for FY2024, which is 22.97% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Other Non-Current Assets of $49.4 million as of Q3 2025, which was down 4.98% from $52.0 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non-Current Assets ranged from a high of $127.0 million in Q1 2023 and a low of $4.1 million during Q3 2021.
  • For the 3-year period, Maravai Lifesciences Holdings' Other Non-Current Assets averaged around $72.8 million, with its median value being $63.5 million (2024).
  • Within the past 5 years, the most significant YoY rise in Maravai Lifesciences Holdings' Other Non-Current Assets was 2,028.57% (2022), while the steepest drop was 42.08% (2022).
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Other Non-Current Assets stood at $53.5 million in 2021, then surged by 116.25% to $115.6 million in 2022, then slumped by 32.85% to $77.6 million in 2023, then dropped by 22.97% to $59.8 million in 2024, then dropped by 18.91% to $49.4 million in 2025.
  • Its Other Non-Current Assets was $49.4 million in Q3 2025, compared to $52.0 million in Q2 2025 and $57.6 million in Q1 2025.